-
Founded in:
1996-11-27 -
Country:
China -
Address:
No. 378, Jianlu Road, Pudong New Area, Shanghai -
Tax NO.:
91310000630459924R -
Registered Funds:
1,341,172,692 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zidovudine |
This product is an antiviral drug with high activity against retroviruses including human immunodeficiency virus (HIV) in vitro. It is phosphorylated by thymidine kinase in virus-infected cells to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to termination of HIV chain synthesis and thus preventing HIV replication.
More
This product is an antiviral drug with high activity against retroviruses including human immunodeficiency virus (HIV) in vitro. It is phosphorylated by thymidine kinase in virus-infected cells to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to termination of HIV chain synthesis and thus preventing HIV replication. |
30516-87-1 | 36 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zidovudine |
This product is an antiviral drug with high activity against retroviruses including human immunodeficiency virus (HIV) in vitro. It is phosphorylated by thymidine kinase in virus-infected cells to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to termination of HIV chain synthesis and thus preventing HIV replication.
More
This product is an antiviral drug with high activity against retroviruses including human immunodeficiency virus (HIV) in vitro. It is phosphorylated by thymidine kinase in virus-infected cells to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to termination of HIV chain synthesis and thus preventing HIV replication. |
30516-87-1 | 36 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zidovudine |
This product is an antiviral drug with high activity against retroviruses including human immunodeficiency virus (HIV) in vitro. It is phosphorylated by thymidine kinase in virus-infected cells to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to termination of HIV chain synthesis and thus preventing HIV replication.
More
This product is an antiviral drug with high activity against retroviruses including human immunodeficiency virus (HIV) in vitro. It is phosphorylated by thymidine kinase in virus-infected cells to zidovudine triphosphate, which can selectively inhibit HIV reverse transcriptase, leading to termination of HIV chain synthesis and thus preventing HIV replication. |
30516-87-1 | 36 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Simvastatin |
Simvastatin reduces normal and elevated low-density lipoprotein cholesterol (LDL-C) levels, lowering LDL by reducing VLDL cholesterol concentrations and inducing the formation of LDL receptors, resulting in reduced production and/or increased catabolism of LDL-C. In addition, simvastatin reduces apolipoprotein B (ApoB), VLDL, and triglycerides (TG), and increases HDL-C.
More
Simvastatin reduces normal and elevated low-density lipoprotein cholesterol (LDL-C) levels, lowering LDL by reducing VLDL cholesterol concentrations and inducing the formation of LDL receptors, resulting in reduced production and/or increased catabolism of LDL-C. In addition, simvastatin reduces apolipoprotein B (ApoB), VLDL, and triglycerides (TG), and increases HDL-C. |
79902-63-9 | 63 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
No specific pharmacological information is provided
More
No specific pharmacological information is provided |
23593-75-1 | 46 |